Institutional Biosafety/recombinant DNA Committee (IBC) Charter
I. Introduction | II. Roles and Responsibilities | III. Research | IV. IBC Membership | V. IBC Policies and Procedures | VI. Protocol Review Process
Show as single page
    I. Introduction
  • The University of Texas at El Paso (UTEP) follows the National Institutes of Health (NIH) system for enhancing science through safety and ethics of recombinant or synthetic nucleic acid (rDNA) research. The responsibility of NIH oversight of rDNA research lies with the NIH Office of Science Policy (OSP) also known as Office of Biotechnology Activities (OBA). UTEP uses the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, the Institutional Biosafety Committee (IBC), and the NIH Recombinant DNA Advisory Committee (RAC) as key tools for biosafety and rDNA research oversight. The NIH Guidelines are intended to assist UTEP, the IBC, the Biological Safety Officer (BSO) and the Principal Investigators in determining the safeguards that must be implemented to conduct rDNA research. This document outlines the responsibilities and procedures that the UTEP IBC uses to implement, promote and manage safe and ethical rDNA research at UTEP.

I. Introduction | Page 1 of 6 | II. Roles and Responsibilities


The University of Texas at El Paso  |  Terms Of Use  |  Privacy Statement  |  Required Links